We first surveyed survivin mRNA expression in human muscloskeletal tumor tissue samples, and found that survivin mRNA expression in MFH/UPS samples was significantly higher than expression in samples from benign schwannomas. This evidence concerns the gene BIRC5 and schwannoma.